Truist Securities Reiterates Buy Rating on Gilead Sciences (GILD)
Tweet Send to a Friend
Truist Securities analyst Greg Renza reiterated a Buy rating and $152.00 price target on Gilead Sciences (NASDAQ: GILD).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
